Global Systemic Candidiasis Supply, Demand and Key Producers, 2024-2030

Description

The global Systemic Candidiasis market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Systemic candidiasis includes a spectrum of yeast infections caused by different species (types) of Candida. It is a serious infection that can affect the blood, heart, brain, eyes, bones, or other parts of the body.

This report studies the global Systemic Candidiasis demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Systemic Candidiasis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Systemic Candidiasis that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Systemic Candidiasis total market, 2019-2030, (USD Million)
Global Systemic Candidiasis total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Systemic Candidiasis total market, key domestic companies and share, (USD Million)
Global Systemic Candidiasis revenue by player and market share 2019-2024, (USD Million)
Global Systemic Candidiasis total market by Type, CAGR, 2019-2030, (USD Million)
Global Systemic Candidiasis total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Systemic Candidiasis market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis Ag, Sanofi-Aventis, Pfizer, Inc., Merck And Co., Inc., Enzon Pharmaceuticals Inc., Bayer Ag, Astellas Pharma, Inc., Glaxosmithkline Plc and Abbott, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Systemic Candidiasis market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Systemic Candidiasis Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Systemic Candidiasis Market, Segmentation by Type
    Systemic Oral Azoles
    Voriconazole
    Liposomal Amphotericin B
    Topical Antifungal Agents
    Others

Global Systemic Candidiasis Market, Segmentation by Application
    Hospital
    Clinic
    Others

Companies Profiled:
    Novartis Ag
    Sanofi-Aventis
    Pfizer, Inc.
    Merck And Co., Inc.
    Enzon Pharmaceuticals Inc.
    Bayer Ag
    Astellas Pharma, Inc.
    Glaxosmithkline Plc
    Abbott
    Cipla

Key Questions Answered
1. How big is the global Systemic Candidiasis market?
2. What is the demand of the global Systemic Candidiasis market?
3. What is the year over year growth of the global Systemic Candidiasis market?
4. What is the total value of the global Systemic Candidiasis market?
5. Who are the major players in the global Systemic Candidiasis market?

Table of Contents

1 Supply Summary
    1.1 Systemic Candidiasis Introduction
    1.2 World Systemic Candidiasis Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Systemic Candidiasis Total Market by Region (by Headquarter Location)
        1.3.1 World Systemic Candidiasis Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Systemic Candidiasis Market Size (2019-2030)
        1.3.3 China Systemic Candidiasis Market Size (2019-2030)
        1.3.4 Europe Systemic Candidiasis Market Size (2019-2030)
        1.3.5 Japan Systemic Candidiasis Market Size (2019-2030)
        1.3.6 South Korea Systemic Candidiasis Market Size (2019-2030)
        1.3.7 ASEAN Systemic Candidiasis Market Size (2019-2030)
        1.3.8 India Systemic Candidiasis Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Systemic Candidiasis Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Systemic Candidiasis Major Market Trends

2 Demand Summary
    2.1 World Systemic Candidiasis Consumption Value (2019-2030)
    2.2 World Systemic Candidiasis Consumption Value by Region
        2.2.1 World Systemic Candidiasis Consumption Value by Region (2019-2024)
        2.2.2 World Systemic Candidiasis Consumption Value Forecast by Region (2025-2030)
    2.3 United States Systemic Candidiasis Consumption Value (2019-2030)
    2.4 China Systemic Candidiasis Consumption Value (2019-2030)
    2.5 Europe Systemic Candidiasis Consumption Value (2019-2030)
    2.6 Japan Systemic Candidiasis Consumption Value (2019-2030)
    2.7 South Korea Systemic Candidiasis Consumption Value (2019-2030)
    2.8 ASEAN Systemic Candidiasis Consumption Value (2019-2030)
    2.9 India Systemic Candidiasis Consumption Value (2019-2030)

3 World Systemic Candidiasis Companies Competitive Analysis
    3.1 World Systemic Candidiasis Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Systemic Candidiasis Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Systemic Candidiasis in 2023
        3.2.3 Global Concentration Ratios (CR8) for Systemic Candidiasis in 2023
    3.3 Systemic Candidiasis Company Evaluation Quadrant
    3.4 Systemic Candidiasis Market: Overall Company Footprint Analysis
        3.4.1 Systemic Candidiasis Market: Region Footprint
        3.4.2 Systemic Candidiasis Market: Company Product Type Footprint
        3.4.3 Systemic Candidiasis Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Systemic Candidiasis Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Systemic Candidiasis Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Systemic Candidiasis Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Systemic Candidiasis Consumption Value Comparison
        4.2.1 United States VS China: Systemic Candidiasis Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Systemic Candidiasis Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Systemic Candidiasis Companies and Market Share, 2019-2024
        4.3.1 United States Based Systemic Candidiasis Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Systemic Candidiasis Revenue, (2019-2024)
    4.4 China Based Companies Systemic Candidiasis Revenue and Market Share, 2019-2024
        4.4.1 China Based Systemic Candidiasis Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Systemic Candidiasis Revenue, (2019-2024)
    4.5 Rest of World Based Systemic Candidiasis Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Systemic Candidiasis Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Systemic Candidiasis Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Systemic Candidiasis Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Systemic Oral Azoles
        5.2.2 Voriconazole
        5.2.3 Liposomal Amphotericin B
        5.2.4 Topical Antifungal Agents
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Systemic Candidiasis Market Size by Type (2019-2024)
        5.3.2 World Systemic Candidiasis Market Size by Type (2025-2030)
        5.3.3 World Systemic Candidiasis Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Systemic Candidiasis Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Systemic Candidiasis Market Size by Application (2019-2024)
        6.3.2 World Systemic Candidiasis Market Size by Application (2025-2030)
        6.3.3 World Systemic Candidiasis Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Novartis Ag
        7.1.1 Novartis Ag Details
        7.1.2 Novartis Ag Major Business
        7.1.3 Novartis Ag Systemic Candidiasis Product and Services
        7.1.4 Novartis Ag Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Novartis Ag Recent Developments/Updates
        7.1.6 Novartis Ag Competitive Strengths & Weaknesses
    7.2 Sanofi-Aventis
        7.2.1 Sanofi-Aventis Details
        7.2.2 Sanofi-Aventis Major Business
        7.2.3 Sanofi-Aventis Systemic Candidiasis Product and Services
        7.2.4 Sanofi-Aventis Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Sanofi-Aventis Recent Developments/Updates
        7.2.6 Sanofi-Aventis Competitive Strengths & Weaknesses
    7.3 Pfizer, Inc.
        7.3.1 Pfizer, Inc. Details
        7.3.2 Pfizer, Inc. Major Business
        7.3.3 Pfizer, Inc. Systemic Candidiasis Product and Services
        7.3.4 Pfizer, Inc. Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Pfizer, Inc. Recent Developments/Updates
        7.3.6 Pfizer, Inc. Competitive Strengths & Weaknesses
    7.4 Merck And Co., Inc.
        7.4.1 Merck And Co., Inc. Details
        7.4.2 Merck And Co., Inc. Major Business
        7.4.3 Merck And Co., Inc. Systemic Candidiasis Product and Services
        7.4.4 Merck And Co., Inc. Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Merck And Co., Inc. Recent Developments/Updates
        7.4.6 Merck And Co., Inc. Competitive Strengths & Weaknesses
    7.5 Enzon Pharmaceuticals Inc.
        7.5.1 Enzon Pharmaceuticals Inc. Details
        7.5.2 Enzon Pharmaceuticals Inc. Major Business
        7.5.3 Enzon Pharmaceuticals Inc. Systemic Candidiasis Product and Services
        7.5.4 Enzon Pharmaceuticals Inc. Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Enzon Pharmaceuticals Inc. Recent Developments/Updates
        7.5.6 Enzon Pharmaceuticals Inc. Competitive Strengths & Weaknesses
    7.6 Bayer Ag
        7.6.1 Bayer Ag Details
        7.6.2 Bayer Ag Major Business
        7.6.3 Bayer Ag Systemic Candidiasis Product and Services
        7.6.4 Bayer Ag Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Bayer Ag Recent Developments/Updates
        7.6.6 Bayer Ag Competitive Strengths & Weaknesses
    7.7 Astellas Pharma, Inc.
        7.7.1 Astellas Pharma, Inc. Details
        7.7.2 Astellas Pharma, Inc. Major Business
        7.7.3 Astellas Pharma, Inc. Systemic Candidiasis Product and Services
        7.7.4 Astellas Pharma, Inc. Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Astellas Pharma, Inc. Recent Developments/Updates
        7.7.6 Astellas Pharma, Inc. Competitive Strengths & Weaknesses
    7.8 Glaxosmithkline Plc
        7.8.1 Glaxosmithkline Plc Details
        7.8.2 Glaxosmithkline Plc Major Business
        7.8.3 Glaxosmithkline Plc Systemic Candidiasis Product and Services
        7.8.4 Glaxosmithkline Plc Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Glaxosmithkline Plc Recent Developments/Updates
        7.8.6 Glaxosmithkline Plc Competitive Strengths & Weaknesses
    7.9 Abbott
        7.9.1 Abbott Details
        7.9.2 Abbott Major Business
        7.9.3 Abbott Systemic Candidiasis Product and Services
        7.9.4 Abbott Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Abbott Recent Developments/Updates
        7.9.6 Abbott Competitive Strengths & Weaknesses
    7.10 Cipla
        7.10.1 Cipla Details
        7.10.2 Cipla Major Business
        7.10.3 Cipla Systemic Candidiasis Product and Services
        7.10.4 Cipla Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Cipla Recent Developments/Updates
        7.10.6 Cipla Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Systemic Candidiasis Industry Chain
    8.2 Systemic Candidiasis Upstream Analysis
    8.3 Systemic Candidiasis Midstream Analysis
    8.4 Systemic Candidiasis Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Systemic Candidiasis Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Systemic Candidiasis Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Systemic Candidiasis Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Systemic Candidiasis Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Systemic Candidiasis Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Systemic Candidiasis Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Systemic Candidiasis Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Systemic Candidiasis Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Systemic Candidiasis Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Systemic Candidiasis Players in 2023
    Table 12. World Systemic Candidiasis Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Systemic Candidiasis Company Evaluation Quadrant
    Table 14. Head Office of Key Systemic Candidiasis Player
    Table 15. Systemic Candidiasis Market: Company Product Type Footprint
    Table 16. Systemic Candidiasis Market: Company Product Application Footprint
    Table 17. Systemic Candidiasis Mergers & Acquisitions Activity
    Table 18. United States VS China Systemic Candidiasis Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Systemic Candidiasis Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Systemic Candidiasis Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Systemic Candidiasis Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Systemic Candidiasis Revenue Market Share (2019-2024)
    Table 23. China Based Systemic Candidiasis Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Systemic Candidiasis Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Systemic Candidiasis Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Systemic Candidiasis Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Systemic Candidiasis Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Systemic Candidiasis Revenue Market Share (2019-2024)
    Table 29. World Systemic Candidiasis Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Systemic Candidiasis Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Systemic Candidiasis Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Systemic Candidiasis Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Systemic Candidiasis Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Systemic Candidiasis Market Size by Application (2025-2030) & (USD Million)
    Table 35. Novartis Ag Basic Information, Area Served and Competitors
    Table 36. Novartis Ag Major Business
    Table 37. Novartis Ag Systemic Candidiasis Product and Services
    Table 38. Novartis Ag Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Novartis Ag Recent Developments/Updates
    Table 40. Novartis Ag Competitive Strengths & Weaknesses
    Table 41. Sanofi-Aventis Basic Information, Area Served and Competitors
    Table 42. Sanofi-Aventis Major Business
    Table 43. Sanofi-Aventis Systemic Candidiasis Product and Services
    Table 44. Sanofi-Aventis Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Sanofi-Aventis Recent Developments/Updates
    Table 46. Sanofi-Aventis Competitive Strengths & Weaknesses
    Table 47. Pfizer, Inc. Basic Information, Area Served and Competitors
    Table 48. Pfizer, Inc. Major Business
    Table 49. Pfizer, Inc. Systemic Candidiasis Product and Services
    Table 50. Pfizer, Inc. Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Pfizer, Inc. Recent Developments/Updates
    Table 52. Pfizer, Inc. Competitive Strengths & Weaknesses
    Table 53. Merck And Co., Inc. Basic Information, Area Served and Competitors
    Table 54. Merck And Co., Inc. Major Business
    Table 55. Merck And Co., Inc. Systemic Candidiasis Product and Services
    Table 56. Merck And Co., Inc. Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Merck And Co., Inc. Recent Developments/Updates
    Table 58. Merck And Co., Inc. Competitive Strengths & Weaknesses
    Table 59. Enzon Pharmaceuticals Inc. Basic Information, Area Served and Competitors
    Table 60. Enzon Pharmaceuticals Inc. Major Business
    Table 61. Enzon Pharmaceuticals Inc. Systemic Candidiasis Product and Services
    Table 62. Enzon Pharmaceuticals Inc. Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Enzon Pharmaceuticals Inc. Recent Developments/Updates
    Table 64. Enzon Pharmaceuticals Inc. Competitive Strengths & Weaknesses
    Table 65. Bayer Ag Basic Information, Area Served and Competitors
    Table 66. Bayer Ag Major Business
    Table 67. Bayer Ag Systemic Candidiasis Product and Services
    Table 68. Bayer Ag Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Bayer Ag Recent Developments/Updates
    Table 70. Bayer Ag Competitive Strengths & Weaknesses
    Table 71. Astellas Pharma, Inc. Basic Information, Area Served and Competitors
    Table 72. Astellas Pharma, Inc. Major Business
    Table 73. Astellas Pharma, Inc. Systemic Candidiasis Product and Services
    Table 74. Astellas Pharma, Inc. Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Astellas Pharma, Inc. Recent Developments/Updates
    Table 76. Astellas Pharma, Inc. Competitive Strengths & Weaknesses
    Table 77. Glaxosmithkline Plc Basic Information, Area Served and Competitors
    Table 78. Glaxosmithkline Plc Major Business
    Table 79. Glaxosmithkline Plc Systemic Candidiasis Product and Services
    Table 80. Glaxosmithkline Plc Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Glaxosmithkline Plc Recent Developments/Updates
    Table 82. Glaxosmithkline Plc Competitive Strengths & Weaknesses
    Table 83. Abbott Basic Information, Area Served and Competitors
    Table 84. Abbott Major Business
    Table 85. Abbott Systemic Candidiasis Product and Services
    Table 86. Abbott Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Abbott Recent Developments/Updates
    Table 88. Cipla Basic Information, Area Served and Competitors
    Table 89. Cipla Major Business
    Table 90. Cipla Systemic Candidiasis Product and Services
    Table 91. Cipla Systemic Candidiasis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 92. Global Key Players of Systemic Candidiasis Upstream (Raw Materials)
    Table 93. Systemic Candidiasis Typical Customers
List of Figure
    Figure 1. Systemic Candidiasis Picture
    Figure 2. World Systemic Candidiasis Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Systemic Candidiasis Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Systemic Candidiasis Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Systemic Candidiasis Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Systemic Candidiasis Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Systemic Candidiasis Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Systemic Candidiasis Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Systemic Candidiasis Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Systemic Candidiasis Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Systemic Candidiasis Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Systemic Candidiasis Revenue (2019-2030) & (USD Million)
    Figure 13. Systemic Candidiasis Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Systemic Candidiasis Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Systemic Candidiasis Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Systemic Candidiasis Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Systemic Candidiasis Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Systemic Candidiasis Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Systemic Candidiasis Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Systemic Candidiasis Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Systemic Candidiasis Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Systemic Candidiasis Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Systemic Candidiasis by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Systemic Candidiasis Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Systemic Candidiasis Markets in 2023
    Figure 27. United States VS China: Systemic Candidiasis Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Systemic Candidiasis Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Systemic Candidiasis Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Systemic Candidiasis Market Size Market Share by Type in 2023
    Figure 31. Systemic Oral Azoles
    Figure 32. Voriconazole
    Figure 33. Liposomal Amphotericin B
    Figure 34. Topical Antifungal Agents
    Figure 35. Others
    Figure 36. World Systemic Candidiasis Market Size Market Share by Type (2019-2030)
    Figure 37. World Systemic Candidiasis Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 38. World Systemic Candidiasis Market Size Market Share by Application in 2023
    Figure 39. Hospital
    Figure 40. Clinic
    Figure 41. Others
    Figure 42. Systemic Candidiasis Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Companies Mentioned

Novartis Ag
Sanofi-Aventis
Pfizer, Inc.
Merck And Co., Inc.
Enzon Pharmaceuticals Inc.
Bayer Ag
Astellas Pharma, Inc.
Glaxosmithkline Plc
Abbott
Cipla